the role of notch signaling pathway in the development of craniofacial structures
DOI:
https://doi.org/10.17533/udea.rfo.14000Keywords:
NOTCH pathway, Craniofacial development, Palatogenesis, Jagged 1Abstract
The NOTCH signaling pathway is a cell-cell signaling mechanism evolutionarily conserved among species, which is essential for proper embryonic development as it participates in a variety of cellular processes such as proliferation, differentiation, apoptosis, epithelial- mesenchymal transformation, migration, angiogenesis, stem cell maintenance, and cell fate determination. Several genes of this pathway have been implicated in the development of craniofacial structures. 80% of Alagille syndrome patients have mutations in the gene that codes for receptor Jagged1 (Jag1), along with midface hypoplasia and sporadic craniosynostosis. Mice with gene Jagged2 (Jag2) homozygous mutations present cleft palate as a result of ectopic fusions between the tongue and palatal processes. Similarly, mutations induced in the Hes1 gene produce developmental defects in craniofacial structures resulting from cranial neural crest cells (CrnNC), including cleft palate, frontal bone agenesis, cranial base malformation, and reduced size of upper and lower maxilla. Recent studies have shown alterations during tooth morphogenesis in Jagged2-/- mutant mice, accompanied by defects in ameloblasts cytodifferentiation and poor enamel matrix deposition. These studies show that NOTCH signaling pathway is involved in the development of a variety of craniofacial structures such as palate, teeth, maxillaries, and skull. The purpose of this article is to review the different functions of NOTCH signaling during the development of these craniofacial structures and the alterations resulting from mutations in some NOTCH signaling genes such as Jagged2, Jagged1, Hes1, Notch1, and Notch2.
Downloads
References
Gross JB, Hanken J. Review of fate-mapping studies of osteogenic cranial neural crest in vertebrates. Deve Biol 2008; 317(2): 389-400.
Marcucio RS, Cordero DR, Hu D, Helms JA. Molecular interactions coordinating the development of the forebrain and face. Dev Biol 2005; 284(1): 48-61.
Szabo-Rogers HL, Smithers LE, Yakob W, Liu KJ. New directions in craniofacial morphogenesis. Dev Biol 2010; 341(1): 84-94.
Chambers D, McGonnell IM. Neural crest: facing the facts of head development. Trends Genet 2002; 18(8): 381-384.
Le Douarin NM, Brito JM, Creuzet S. Role of the neural crest in face and brain development. Brain Rev 2007; 55(2): 237-247.
Helms JA, Cordero D, Tapadia MD. New insights into craniofacial morphogenesis. Development. 2005; 132(5): 851-861.
Cordero DR, Brugmann S, Chu Y, Bajpai R, Jame M, Helms JA. Cranial neural crest cells on the move: their roles in craniofacial development. Am J Med Genet 2011; 155A(2): 270-279.
Nie X, Luukko K, Kettunen P. BMP signalling in craniofacial development. Int J Dev Biol 2006; 50(6): 511-521.
Paiva KB, Silva-Valenzuela Md, Massironi SM, Ko GM, Siqueira FM, Nunes FD. Differential Shh, Bmp and Wnt gene expressions during craniofacial development in mice. Acta histochem 2010; 112(5): 508-517.
Casey LM, Lan Y, Cho ES, Maltby KM, Gridley T, Jiang R. Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. Dev Dyn 2006; 235(7): 1830-1844.
Loomes KM, Stevens SA, O’Brien ML, Gonzalez DM, Ryan MJ, Segalov M et al. Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects. Dev Dyn 2007; 236(10): 2943-2951.
Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284(5415): 770-776.
Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, Serreze DV et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 1998; 12(7): 1046-1057.
Mitsiadis TA, Graf D, Luder H, Gridley T, Bluteau G. BMPs and FGFs target Notch signalling via Jagged2 to regulate tooth morphogenesis and cytodifferentiation. Development 2010; 137(18): 3025-3035.
Akimoto M, Kameda Y, Arai Y, Miura M, Nishimaki T, Takeda A et al. Hes1 is required for the development of craniofacial structures derived from ectomesenchymal neural crest cells. J Craniofac Surg 2010; 21(5): 1443-1449.
Warthen DM, Moore EC, Kamath BM, Morrissette JJ, Sanchez-Lara PA, Piccoli DA et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat 2006; 27(5): 436-443.
Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999; 29(3): 822-829.
McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA et al. Notch2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79(1): 169-173.
Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol 2012; 23(4): 450-457.
Bolos V, Grego-Bessa J, de la Pompa JL. Notch signaling in development and cancer. Endocr Rev 2007; 28(3): 339-363.
Pan Y, Liu Z, Shen J, Kopan R. Notch1 and 2 cooperate in limb ectoderm to receive an early Jagged2 signal regulating interdigital apoptosis. Dev Biol 2005; 286(2): 472-482.
Fiuza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol 2007; 194(3): 459-474.
Gordon WR, Arnett KL, Blacklow SC. The molecular logic of Notch signaling a structural and biochemical perspective. J Cell Sci 2008; 121(Pt 19): 3109-3119.
Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284(5415): 770-776.
Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol 2008; 3: 587-613.
Aster JC. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 2005; 82(4): 295-301.
Gritli-Linde A. Molecular control of secondary palate development. Dev Biol 2007; 301(2): 309-326.
Dudas M, Li WY, Kim J, Yang A, Kaartinen V. Palatal fusion - where do the midline cells go? A review on cleft palate, a major human birth defect. Acta histochem 2007; 109(1): 1-14.
Din SU. Atypical tongue-tie due to congenital tongue-palate fusion. J Coll Physicians Surg Pak 2003; 13(8): 459-460.
Humphrey T. Palatopharyngeal fusion in a human fetus and its relation to cleft palate formation. Ala J Med Sci 1970; 7(4): 398-426.
Richardson RJ, Dixon J, Jiang R, Dixon MJ. Integration of IRF6 and Jagged2 signalling is essential for controlling palatal adhesion and fusion competence. Hum Mol Genet 2009; 18(14): 2632-2642.
Mitsiadis TA, Lardelli M, Lendahl U, Thesleff I. Expression of Notch 1, 2 and 3 is regulated by epithelial-mesenchymal interactions and retinoic acid in the developing mouse tooth and associated with determination of ameloblast cell fate. J Cell Biol 1995; 130(2): 407-418.
Mitsiadis TA, Hirsinger E, Lendahl U, Goridis C. Delta-notch signaling in odontogenesis: correlation with cytodifferentiation and evidence for feedback regulation. Dev Biol 1998; 204(2): 420-431.
Mitsiadis TA, Henrique D, Thesleff I, Lendahl U. Mouse Serrate-1 (Jagged-1): expression in the developing tooth is regulated by epithelial mesenchymal interactions and fibroblast growth factor-4. Development 1997; 124(8): 1473-1483.
Mitsiadis TA, Regaudiat L, Gridley T. Role of the Notch signalling pathway in tooth morphogenesis. Arch Oral Biol 2005; 50(2): 137-140.
Valsecchi C, Ghezzi C, Ballabio A, Rugarli EI. JAGGED2: a putative Notch ligand expressed in the apical ectodermal ridge and in sites of epithelial-mesenchymal interactions. Mech Dev 1997; 69(1-2): 203-207.
Harada H, Kettunen P, Jung HS, Mustonen T, Wang YA, Thesleff I. Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. J Cell Biol 1999; 147(1): 105-120.
Mustonen T, Tummers M, Mikami T, Itoh N, Zhang N, Gridley T et al. Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. Deve Biol 2002; 248(2): 281-293.
Felszeghy S, Suomalainen M, Thesleff I. Notch signalling is required for the survival of epithelial stem cells in the continuously growing incisor. Differentiation 2010; 80(4-5): 241-248.
Kamath BM, Loomes KM, Oakey RJ, Emerick KE, Conversano T, Spinner NB et al. Facial features in Alagille syndrome: specific or cholestasis facies? Am J Med Genet 2002; 112(2): 163-170.
Yuan ZR, Kohsaka T, Ikegaya T, Suzuki T, Okano S, Abe J et al. Mutational analysis of the Jagged 1 gene in Alagille syndrome families. Hum Mol Genet 1998; 7(9): 1363-1369.
Kamath BM, Bauer RC, Loomes KM, Chao G, Gerfen J, Hutchinson A et al. NOTCH2 mutations in Alagille syndrome. J Med Genet 2012; 49(2): 138-144.
Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2012; 20(3): 251-257.
Kamath BM, Stolle C, Bason L, Colliton RP, Piccoli DA, Spinner NB et al. Craniosynostosis in Alagille syndrome. Am J Hum Genet 2002; 112(2): 176-180.
Piccoli DA, Spinner NB. Alagille syndrome and the Jagged1 gene. Semin Liver Dis 2001; 21(4): 525-534.
Lorent K, Yeo SY, Oda T, Chandrasekharappa S, Chitnis A, Matthews RP et al. Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development 2004; 131(22): 5753-5766.
McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002; 129(4): 1075-1082.
Zuniga E, Stellabotte F, Crump JG. Jagged-Notch signaling ensures dorsal skeletal identity in the vertebrate face. Development 2010; 137(11): 1843-1852.
Humphreys R, Zheng W, Prince LS, Qu X, Brown C, Loomes K et al. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum Mol Genet 2012; 21(6): 1374-1383.
Yen HY, Ting MC, Maxson RE. Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells. Dev Biol 2010; 347(2): 258-270.
Zanotti S, Canalis E. Notch signaling in skeletal health and disease. Eur J Endocrinol 2013; 168(6): R95-103.
Zanotti S, Canalis E. Notch regulation of bone development and remodeling and related skeletal disorders. Calcif Tissue Int 2012; 90(2): 69-75.
Isidor B, Lindenbaum P, Pichon O, Bézieau S, Dina C, Jacquemont S et al. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet 2011; 43(4): 306-308.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2014 Revista Facultad de Odontología Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice
Copyright comprises moral and patrimonial rights.
1. Moral rights: are born at the moment of the creation of the work, without the need to register it. They belong to the author in a personal and unrelinquishable manner; also, they are imprescriptible, unalienable and non negotiable. Moral rights are the right to paternity of the work, the right to integrity of the work, the right to maintain the work unedited or to publish it under a pseudonym or anonymously, the right to modify the work, the right to repent and, the right to be mentioned, in accordance with the definitions established in article 40 of Intellectual property bylaws of the Universidad (RECTORAL RESOLUTION 21231 of 2005).
2. Patrimonial rights: they consist of the capacity of financially dispose and benefit from the work trough any mean. Also, the patrimonial rights are relinquishable, attachable, prescriptive, temporary and transmissible, and they are caused with the publication or divulgation of the work. To the effect of publication of articles in the journal Revista de la Facultad de Odontología, it is understood that Universidad de Antioquia is the owner of the patrimonial rights of the contents of the publication.
The content of the publications is the exclusive responsibility of the authors. Neither the printing press, nor the editors, nor the Editorial Board will be responsible for the use of the information contained in the articles.
I, we, the author(s), and through me (us), the Entity for which I, am (are) working, hereby transfer in a total and definitive manner and without any limitation, to the Revista Facultad de Odontología Universidad de Antioquia, the patrimonial rights corresponding to the article presented for physical and digital publication. I also declare that neither this article, nor part of it has been published in another journal.
Open Access Policy
The articles published in our Journal are fully open access, as we consider that providing the public with free access to research contributes to a greater global exchange of knowledge.
Creative Commons License
The Journal offers its content to third parties without any kind of economic compensation or embargo on the articles. Articles are published under the terms of a Creative Commons license, known as Attribution – NonCommercial – Share Alike (BY-NC-SA), which permits use, distribution and reproduction in any medium, provided that the original work is properly cited and that the new productions are licensed under the same conditions.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
